Intech Investment Management LLC Buys 57,726 Shares of agilon health, inc. (NYSE:AGL)

Intech Investment Management LLC increased its holdings in shares of agilon health, inc. (NYSE:AGL - Free Report) by 99.6% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 115,693 shares of the company's stock after purchasing an additional 57,726 shares during the quarter. Intech Investment Management LLC's holdings in agilon health were worth $220,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently bought and sold shares of AGL. Oak Thistle LLC acquired a new stake in shares of agilon health in the fourth quarter worth $25,000. Ieq Capital LLC purchased a new stake in agilon health during the 4th quarter worth $26,000. Signaturefd LLC increased its holdings in agilon health by 143.0% in the 4th quarter. Signaturefd LLC now owns 14,388 shares of the company's stock valued at $27,000 after purchasing an additional 8,467 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. purchased a new position in agilon health in the third quarter valued at about $28,000. Finally, Raymond James Financial Inc. acquired a new position in shares of agilon health during the fourth quarter worth about $33,000.

agilon health Price Performance

AGL traded down $0.13 during trading on Friday, hitting $4.48. The company's stock had a trading volume of 3,482,811 shares, compared to its average volume of 4,640,700. agilon health, inc. has a 12 month low of $1.50 and a 12 month high of $7.73. The stock has a market capitalization of $1.85 billion, a price-to-earnings ratio of -4.77 and a beta of 0.67. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. The firm's 50 day moving average price is $3.67 and its two-hundred day moving average price is $2.97.

Remove Ads

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on the company. Stifel Nicolaus increased their target price on agilon health from $2.00 to $3.00 and gave the company a "hold" rating in a research note on Wednesday, February 26th. Needham & Company LLC restated a "hold" rating on shares of agilon health in a research note on Friday, March 21st. Sanford C. Bernstein boosted their price objective on agilon health from $2.50 to $3.15 and gave the company a "market perform" rating in a report on Wednesday, January 15th. Macquarie started coverage on agilon health in a report on Monday, December 16th. They set a "neutral" rating and a $3.00 target price on the stock. Finally, Royal Bank of Canada boosted their target price on shares of agilon health from $3.00 to $3.50 and gave the company an "outperform" rating in a research note on Wednesday, February 26th. Two investment analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, agilon health presently has a consensus rating of "Hold" and a consensus price target of $3.95.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.